RIGENERA WORKSHOP
SEPTEMBER 10-11 | BUCHAREST
The technology of obtaining micro-grafts rich in progenitor cells and SVF (stromal vascular fraction) with the protection of the cell matrix, leading to a bioavailability in transplant of over 90%.
Defined by the autologous - homologous character for obtaining and producing micro-grafts, which allows the use of this technology with NATO DNA in the treatment of large burns, diabetic foot, dehiscence, osteoarthritis, vitiligo, alopecia and facial rejuvenation.
Technology authorized by the European Community and, implicitly, Romania, presenting CE marking.
INTERNATIONAL
Prof. Dr. Antonio Graziano
Inventor of RIGENERA
CEO Human Brain Wave
Dr. Carlo Astarita
Training Program Director
RIGENERA
ROMANIA
Dr. Bogdan Ivanescu
Exclusive importer of RIGENERA
CEO Doctor MIT & Stem Sure
Dr. Carlo Astarita
Presenting the RIGENERA technology.
Sef Lucrari Dr. Ana Maria Oproiu
As. Univ. Dr. Adrian Alexandru
Dr. Mihaela Zaharia
Dr. Elena Leica Roban
Dr. Anamaria Grigore
Case study: results after using the RIGENERA technology in the treatment of a big burn within University Emergency Hospital Municipal.
Dr. Carlo Astarita
Coordinating the use of RIGENERA technology in the treatment of a big burn.
Dr. Carlo Astarita
Presenting the RIGENERA technology.
Sef Lucrari Dr. Ana Maria Oproiu
As. Univ. Dr. Adrian Alexandru
Dr. Mihaela Zaharia
Dr. Elena Leica Roban
Dr. Anamaria Grigore
Case study: results after using the RIGENERA technology in the treatment of a big burn within University Emergency Hospital Municipal.
Dr. Carlo Astarita
Coordinating the use of RIGENERA technology in the treatment of leg ulcer.
Dr. Carlo Astarita
Coordinating the use of RIGENERA technology in the treatment of alopecia.
Conclusions, Q&A.
Dr. Carlo Astarita
Presenting the RIGENERA technology.
Sef Lucrari Dr. Ana Maria Oproiu
As. Univ. Dr. Adrian Alexandru
Dr. Mihaela Zaharia
Dr. Elena Leica Roban
Dr. Anamaria Grigore
Case study: results after using the RIGENERA technology in the treatment of a big burn within University Emergency Hospital Municipal.
Dr. Carlo Astarita
Coordinating the use of RIGENERA technology in the treatment of a big burn.
Dr. Carlo Astarita
Presenting the RIGENERA technology.
Sef Lucrari Dr. Ana Maria Oproiu
As. Univ. Dr. Adrian Alexandru
Dr. Mihaela Zaharia
Dr. Elena Leica Roban
Dr. Anamaria Grigore
Case study: results after using the RIGENERA technology in the treatment of a big burn within University Emergency Hospital Municipal.
Dr. Carlo Astarita
Coordinating the use of RIGENERA technology in the treatment of leg ulcer.
Dr. Carlo Astarita
Coordinating the use of RIGENERA technology in the treatment of alopecia.
Conclusions, Q&A.
Please let us know which of the two OPEN SESSIONS you want to sign up either by email or by calling the Key Account Manager RIGENERA.
Please keep in mind that the maximum number of participants is 30 persons.
Ramona Chirita
Key Account Manager